More recently, it has been shown that leucine-rich-alpha2-glycoprotein 1 (LRG1), enriched in the exosomes derived from NSCLC tissue and cells, mediates a proangiogenic effect via the activation of the TGF-β pathway [41]. This evidence concerns the gene LRG1 and non-small cell lung carcinoma.